BRIEF-ImmunoGen announces pricing of $100 mln offering of Senior Notes
June 15, 2016 at 09:14 AM EDT
* Sale of notes is expected to result in $96.7 million net proceeds to Immunogen
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.